{"title":"芒萁对实验性2型糖尿病的抗糖尿病和降血脂作用","authors":"Deepthi Rayilla, P. Goverdhan","doi":"10.9790/3008-1203064447","DOIUrl":null,"url":null,"abstract":"The antidiabetic and antihyperlipidemic effects of ethanolic extract of whole plant of Alternanthera sessilis (EEAS) was investigated in Streptozotocin (STZ) induced type 2 diabetic rats. Diabetes was confirmed after 3 days of single intraperitoneal injection of STZ (35mg/kg) in albino Wistar rats. EEAS (100 and 200mg/kg) and glibenclamide (10mg/kg) orally administered daily for 15 days respectively, blood was withdrawn for glucose determination on 1, 7, 15 days respectively. On 15 th day, overnight fasted rats were sacrificed and blood was collected for determination of high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglycerides (TG). EEAS at doses of 100mg/kg and 200mg/kg showed significant reduction in blood glucose and lipid profiles when compared to diabetic control group. We concluded that EEAS possess antidiabetic and antihyperlipidemic activities.","PeriodicalId":14548,"journal":{"name":"IOSR Journal of Pharmacy and Biological Sciences","volume":"12 1","pages":"44-47"},"PeriodicalIF":0.0000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Anti-Diabetic and Antihyperlipidemic Activities of Alternanthera Sessilis in Experimentally Induced Type 2 Diabetes\",\"authors\":\"Deepthi Rayilla, P. Goverdhan\",\"doi\":\"10.9790/3008-1203064447\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The antidiabetic and antihyperlipidemic effects of ethanolic extract of whole plant of Alternanthera sessilis (EEAS) was investigated in Streptozotocin (STZ) induced type 2 diabetic rats. Diabetes was confirmed after 3 days of single intraperitoneal injection of STZ (35mg/kg) in albino Wistar rats. EEAS (100 and 200mg/kg) and glibenclamide (10mg/kg) orally administered daily for 15 days respectively, blood was withdrawn for glucose determination on 1, 7, 15 days respectively. On 15 th day, overnight fasted rats were sacrificed and blood was collected for determination of high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglycerides (TG). EEAS at doses of 100mg/kg and 200mg/kg showed significant reduction in blood glucose and lipid profiles when compared to diabetic control group. We concluded that EEAS possess antidiabetic and antihyperlipidemic activities.\",\"PeriodicalId\":14548,\"journal\":{\"name\":\"IOSR Journal of Pharmacy and Biological Sciences\",\"volume\":\"12 1\",\"pages\":\"44-47\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IOSR Journal of Pharmacy and Biological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9790/3008-1203064447\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IOSR Journal of Pharmacy and Biological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9790/3008-1203064447","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anti-Diabetic and Antihyperlipidemic Activities of Alternanthera Sessilis in Experimentally Induced Type 2 Diabetes
The antidiabetic and antihyperlipidemic effects of ethanolic extract of whole plant of Alternanthera sessilis (EEAS) was investigated in Streptozotocin (STZ) induced type 2 diabetic rats. Diabetes was confirmed after 3 days of single intraperitoneal injection of STZ (35mg/kg) in albino Wistar rats. EEAS (100 and 200mg/kg) and glibenclamide (10mg/kg) orally administered daily for 15 days respectively, blood was withdrawn for glucose determination on 1, 7, 15 days respectively. On 15 th day, overnight fasted rats were sacrificed and blood was collected for determination of high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglycerides (TG). EEAS at doses of 100mg/kg and 200mg/kg showed significant reduction in blood glucose and lipid profiles when compared to diabetic control group. We concluded that EEAS possess antidiabetic and antihyperlipidemic activities.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
